Literature DB >> 3729347

Penetration of ceftriaxone into human pleural fluid.

G Benoni, E Arosio, L Cuzzolin, B Vaona, M G Raimondi, A Lechi.   

Abstract

The pharmacokinetics of ceftriaxone were studied for seven patients with pleural effusion of various etiologies. All patients received 1 g of antibiotic, administered as an intravenous bolus. The pleural fluid had a high total protein content (6.0 g/dl). Ceftriaxone levels in plasma and in pleural fluid were determined by the agar well diffusion technique. Total and free drug concentrations in pleural fluid reached 7 to 8.7 and 3.8 to 2.3 micrograms/ml, respectively, in 4 to 6 h. The disappearance of the drug from the pleural fluid was very slow. In these patients, therapeutic ceftriaxone levels were present for at least 53 h in pleural fluid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729347      PMCID: PMC284176          DOI: 10.1128/AAC.29.5.906

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  INHIBITORS OF PENICILLIN BINDING TO SERUM PROTEINS.

Authors:  C M KUNIN
Journal:  J Lab Clin Med       Date:  1965-03

2.  A new micromethod for determination of protein in cerebrospinal fluid and urine.

Authors:  M A Pesce; C S Strande
Journal:  Clin Chem       Date:  1973-11       Impact factor: 8.327

3.  Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.

Authors:  W Brumfitt; J Kosmidis; J M Hamilton-Miller; J N Gilchrist
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

4.  Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits.

Authors:  D N Gerding; W H Hall; E A Schierl; R E Manion
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

5.  Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.

Authors:  P Angehrn; P J Probst; R Reiner; R L Then
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

6.  Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.

Authors:  D N Gerding; L R Peterson; D C Legler; W H Hall; E A Schierl
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

7.  Concentrations of ampicillin in pleural fluid and serum after single and repetitive doses of bacampicillin.

Authors:  W Bronsveld; J Stam; D M MacLaren
Journal:  Scand J Infect Dis Suppl       Date:  1978
  7 in total
  5 in total

Review 1.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

3.  Comparative study of penetration of lomefloxacin and ceftriaxone into transudative and exudative pleural effusion.

Authors:  M Kimura; T Matsushima; J Nakamura; Y Kobashi
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

4.  Pharmacokinetics and protein binding of ceftriaxone during pregnancy.

Authors:  P Bourget; H Fernandez; V Quinquis; C Delouis
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of ceftriaxone.

Authors:  J H Yuk; C H Nightingale; R Quintiliani
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.